| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |